321 related articles for article (PubMed ID: 27059345)
1. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
[TBL] [Abstract][Full Text] [Related]
3. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
[TBL] [Abstract][Full Text] [Related]
4. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U
JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186
[TBL] [Abstract][Full Text] [Related]
5. Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Umaña J; Tate J; Lopman B; Sanchez E; Reyes M; Mercado J; Gonzalez A; Perez MC; Balmaceda A; Andrus J; Parashar U
Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
Doll MK; Buckeridge DL; Morrison KT; Gagneur A; Tapiero B; Charest H; Quach C
Vaccine; 2015 Dec; 33(51):7307-7314. PubMed ID: 26546262
[TBL] [Abstract][Full Text] [Related]
7. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of monovalent and pentavalent rotavirus vaccine.
Cortese MM; Immergluck LC; Held M; Jain S; Chan T; Grizas AP; Khizer S; Barrett C; Quaye O; Mijatovic-Rustempasic S; Gautam R; Bowen MD; Moore J; Tate JE; Parashar UD; Vázquez M
Pediatrics; 2013 Jul; 132(1):e25-33. PubMed ID: 23776114
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
Payne DC; Boom JA; Staat MA; Edwards KM; Szilagyi PG; Klein EJ; Selvarangan R; Azimi PH; Harrison C; Moffatt M; Johnston SH; Sahni LC; Baker CJ; Rench MA; Donauer S; McNeal M; Chappell J; Weinberg GA; Tasslimi A; Tate JE; Wikswo M; Curns AT; Sulemana I; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2013 Jul; 57(1):13-20. PubMed ID: 23487388
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
[TBL] [Abstract][Full Text] [Related]
12. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.
Armah G; Pringle K; Enweronu-Laryea CC; Ansong D; Mwenda JM; Diamenu SK; Narh C; Lartey B; Binka F; Grytdal S; Patel M; Parashar U; Lopman B
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S200-7. PubMed ID: 27059357
[TBL] [Abstract][Full Text] [Related]
13. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
[TBL] [Abstract][Full Text] [Related]
15. Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.
Bar-Zeev N; Jere KC; Bennett A; Pollock L; Tate JE; Nakagomi O; Iturriza-Gomara M; Costello A; Mwansambo C; Parashar UD; Heyderman RS; French N; Cunliffe NA;
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S213-9. PubMed ID: 27059359
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U
Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2012 Feb; (2):CD008521. PubMed ID: 22336845
[TBL] [Abstract][Full Text] [Related]
19. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.
Payne DC; Selvarangan R; Azimi PH; Boom JA; Englund JA; Staat MA; Halasa NB; Weinberg GA; Szilagyi PG; Chappell J; McNeal M; Klein EJ; Sahni LC; Johnston SH; Harrison CJ; Baker CJ; Bernstein DI; Moffatt ME; Tate JE; Mijatovic-Rustempasic S; Esona MD; Wikswo ME; Curns AT; Sulemana I; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2015 Dec; 61(12):1792-9. PubMed ID: 26449565
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.
Correia JB; Patel MM; Nakagomi O; Montenegro FM; Germano EM; Correia NB; Cuevas LE; Parashar UD; Cunliffe NA; Nakagomi T
J Infect Dis; 2010 Feb; 201(3):363-9. PubMed ID: 20047501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
